Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231
Open Access
- 1 January 2009
- journal article
- Published by Springer Science and Business Media LLC in Cancer Cell International
- Vol. 9 (1), 1
- https://doi.org/10.1186/1475-2867-9-1
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Mechanism of Synergy of N-(4-Hydroxyphenyl)Retinamide and ABT-737 in Acute Lymphoblastic Leukemia Cell Lines: Mcl-1 InactivationJNCI Journal of the National Cancer Institute, 2008
- Cytotoxic effects of curcumin on osteosarcoma cell linesInvestigational New Drugs, 2007
- Curcumin as “Curecumin”: From kitchen to clinicBiochemical Pharmacology, 2007
- Defects of the apoptotic pathway as therapeutic target against cancerDrug Resistance Updates, 2005
- Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis modelBiochemical and Biophysical Research Communications, 2004
- Matrix metalloproteinase expression in breast cancerJournal of Surgical Research, 2003
- Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xlCarcinogenesis: Integrative Cancer Research, 2002
- Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.1994
- Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous ironMolecular and Cellular Biochemistry, 1994
- Influence of docosahexaenoic acid in vitro on intracellular adriamycin concentration in lymphocytes and human adriamycin‐sensitive and ‐resistant small‐cell lung cancer cell lines, and on cytotoxicity in the tumor cell linesInternational Journal of Cancer, 1987